The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice.

A differentiation induction subtraction hybridization strategy is being used to identify and clone genes involved in growth control and terminal differentiation in human cancer cells. This scheme identified melanoma differentiation associated gene-7 (mda-7), whose expression is up-regulated as a consequence of terminal differentiation in human melanoma cells. Forced expression of mda-7 is growth inhibitory toward diverse human tumor cells. The present studies elucidate the mechanism by which mda-7 selectively suppresses the growth of human breast cancer cells and the consequence of ectopic expression of mda-7 on human breast tumor formation in vivo in nude mice. Infection of wild-type, mutant, and null p53 human breast cancer cells with a recombinant type 5 adenovirus expressing mda-7, Ad.mda-7 S, inhibited growth and induced programmed cell death (apoptosis). Induction of apoptosis correlated with an increase in BAX protein, an established inducer of programmed cell death, and an increase in the ratio of BAX to BCL-2, an established inhibitor of apoptosis. Infection of breast carcinoma cells with Ad.mda-7 S before injection into nude mice inhibited tumor development. In contrast, ectopic expression of mda-7 did not significantly alter cell cycle kinetics, growth rate, or survival in normal human mammary epithelial cells. These data suggest that mda-7 induces its selective anticancer properties in human breast carcinoma cells by promoting apoptosis that occurs independent of p53 status. On the basis of its selective anticancer inhibitory activity and its direct antitumor effects, mda-7 may represent a new class of cancer suppressor genes that could prove useful for the targeted therapy of human cancer.

[1]  H. Jiang,et al.  Melanoma differentiation associated gene-9, mda-9, is a human gamma interferon responsive gene. , 1998, Gene.

[2]  John Calvin Reed Double identity for proteins of the Bcl-2 family , 1997, Nature.

[3]  J C Reed,et al.  Somatic Frameshift Mutations in the BAX Gene in Colon Cancers of the Microsatellite Mutator Phenotype , 1997, Science.

[4]  S. Korsmeyer,et al.  Bax suppresses tumorigenesis and stimulates apoptosis in vivo , 1997, Nature.

[5]  A. Strasser,et al.  Bcl-2, Bcl-xL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death , 1997, Oncogene.

[6]  A. Fattaey,et al.  An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells , 1996, Science.

[7]  P. Branton,et al.  Adenovirus E1B 19-kDa Death Suppressor Protein Interacts with Bax but Not with Bad* , 1996, The Journal of Biological Chemistry.

[8]  Z. Su,et al.  The melanoma differentiation associated gene mda-7 suppresses cancer cell growth. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[9]  B. Dörken,et al.  Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice. , 1996, The Journal of clinical investigation.

[10]  E. White,et al.  The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. , 1996, Genes & development.

[11]  Z. Su,et al.  Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. , 1995, Oncogene.

[12]  Z. Su,et al.  Transcriptional switching model for the regulation of tumorigenesis and metastasis by the ha-ras oncogene - transcriptional changes in the ha-ras tumor-suppressor gene lysyl oxidase. , 1995, International journal of oncology.

[13]  N. Goldstein,et al.  Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  Z. Su,et al.  Apoptosis mediates the selective toxicity of caffeic acid phenethyl ester (CAPE) toward oncogene-transformed rat embryo fibroblast cells. , 1995, Anticancer research.

[15]  Z. Oltvai,et al.  Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Z. Su,et al.  The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. , 1995, Oncogene.

[17]  Madireddi Mt,et al.  Identification of a Novel Polypeptide Involved in the Formation of DNA-Containing Vesicles during Macronuclear Development in Tetrahymena , 1994 .

[18]  S. Korsmeyer,et al.  Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. , 1993, Cancer research.

[19]  S. Ben‐Sasson,et al.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.

[20]  E. White,et al.  Role of adenovirus E1B proteins in transformation: altered organization of intermediate filaments in transformed cells that express the 19-kilodalton protein , 1990 .

[21]  C. Allis,et al.  Timing of the appearance of macronuclear-specific histone variant hv1 and gene expression in developing new macronuclei of Tetrahymena thermophila , 1984, The Journal of cell biology.

[22]  F. Volkert,et al.  The genetic analysis of recombination using adenovirus overlapping terminal DNA fragments. , 1983, Virology.

[23]  P. Fisher,et al.  Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development. , 1998, Current topics in microbiology and immunology.

[24]  E. White,et al.  Life, death, and the pursuit of apoptosis. , 1996, Genes & development.

[25]  J C Reed,et al.  Structure-function analysis of Bcl-2 family proteins. Regulators of programmed cell death. , 1996, Advances in experimental medicine and biology.

[26]  C. Allis,et al.  Identification of a novel polypeptide involved in the formation of DNA-containing vesicles during macronuclear development in Tetrahymena. , 1994, Developmental biology.

[27]  S. Pestka,et al.  Effects of combined treatment with interferon and mezerein on melanogenesis and growth in human melanoma cells. , 1985, Journal of interferon research.